Pyridinium crosslinks in the monitoring of patients with bone metastases from carcinoma of the breast

Clinical Oncology

Volumn 9, Issue 1, 1997, Pages 30-34

  Walne, A J ^a   Jenkins, P J ^a   James, I T ^a   Plowman, P N ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

Bone metastases; Breast cancer; Collagen crosslinks; Pyridinoline

Indexed keywords

COLLAGEN; DEOXYPYRIDINOLINE; MARKER; PYRIDINIUM DERIVATIVE; PYRIDINOLINE;

ADOLESCENT; ADULT; ARTICLE; BLOOD LEVEL; BONE METASTASIS; BREAST CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; COLLAGEN DEGRADATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS LINKING; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; PATIENT MONITORING; PRIORITY JOURNAL; TIME; URINE LEVEL;

EID: 0030896645     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0936-6555(97)80056-8     Document Type: Article

References (23)

1. Blomqvist C, Elomma I, Virkkunen P, et al. The response of bone metastases in mammary carcinoma. Cancer 1987; 60:2907-12.
2. Citrin DL, Hougan C, Zweibel W, et al. The use of serial bone scans in assessing the response of bone metastases to systemic treatment. Cancer 1981;47:680-5.
3. Condon BR, Buchannan R, Garvie NW, et al. Assessment of progression of secondary bone lesions following cancer of the breast or prostate using serial radionuclide imaging. Br J Radiol 1981;54:18-23.
4. Coombes R, Dady P, Parsons C, et al. Assessment of response of bone metastases to systemic treatment in patients with breast cancer. Cancer 1983;52:610-4.
5. Fujimoto D. Isolation and characterization of a fluorescent material in bovine Achilles tendon collagen. Biochem Biophys Res Commun 1977;76:1124-9.
6. Ogawa T, Ono T, Tsuda M, et al. A novel fluor in insoluble collagen: A crosslinking moiety in collagen molecule. Biochem Biophys Res Commun 1982;107:1252-7.
7. Eyre D, Koob T, Van Ness K. Quantitation of hydroxypyridinium crosslinks in collagen by high performance liquid chromatography. Anal Biochem 1984;137:380-8.
8. MacDonald A, McHenry P, Robins S, et al. Relationship of urinary pyridinium crosslinks to disease extent and activity in osteoarthritis. Br J Rheumatol 1994,33:16-19.
9. Black D, Marabani M, Sturrock R, et al. Urinary excretion of the hydroxypyridiniuin crosslinks of collagen in patients with rheumatoid arthritis. Ann Rheum Dis 1989;48:641-4.
10. Seibel M, Gartenberg F, Silverberg S, et al. Urinary hydroxypyridinium crosslinks of collagen in primary hyperparathyroidism. J Clin Endocrinol Metab 1992,74:481-6.
11. Sano M, Kishida K, Takahashi M, et al. Urinary pyridinoline and deoxypyridinoline in prostate carcinoma patients with bone metastases. Br J Cancer 1994;70:701-3.
12. Colwell, A, Russell R, Eastell R. Factors affecting the assay of urinary 3-hydroxypyridinium crosslinks of collagen as markers of bone resorption. Eur j Clin Invest 1993,23:341-9.
13. James IT, Crowley C, Perrett D. Assay of pyridinium crosslinks in serum using narrow bore ion-paired reversed-phase performance liquid chromatography. J Chromatogr Biomed Appl 1993;612:41-8.
14. James IT, Perrett D, Thompson PW. Rapid assay for hard tissue collagen crosslinks using isocratic ion-paired reversed-phase liquid chromatography. J Chromatogr Biomed Appl 1990;525:43-57.
15. Perrett D, White P. HPLC in biomedical and forensic analysis. In: Lough W, Wainer I, editors. HPLC: Fundamental principles and practice. Glasgow: Blackie, 1995:205-33.
16. Arrigoni M, Abbiati G, Galimberti S, et al. Free and total urinary pyridinoline and deoxypyridinoline (LP) analysis. Comparison between 24 hour collection and fasting early morning urine samples. In: Chrisiansen C, Overgaard K, editors. Osteopress (Osteoporosis). Copenhagen: Aps, 1990;596.
17. McLaren A, Isdale A, Whittings P, et al. Physiological variations in the urinary excretion of pyridinium crosslinks of collagen. Br J Rheumatol 1993;32:307-12.
18. Uhishi T, Kushida K, Takahashi M, et al. Urinary bone resorption markers in patients with metabolic bone disorders. Bone 1994;15:15-20.
19. Body J, Delmas P. Urinary pyridinium crosslinks as markers of bone resorption in tumor-associated hypercalcaemia. J Clin Endocrinol Metab 1992;74:471-5.
20. James IT, Quayle J, Cunningham J, et al. The determination of pyridinium crosslinks in the plasma of normal and uraemic patients. Clin Rheumatol 1991;10:457-8.
21. Niwa T, Shiobara K, Hamada T, et al. Serum pyridinolines as specific markers of bone resorption in hemodialyzed patients. Clin Chim Act 1995;235:33-40.
22. Paterson CR, Robins S, Horobin J, et al. Pyridinium crosslinks as markers of bone resorption in patients with breast cancer. Br J Cancer 1991;64:884-6.
23. Lipton A, Demers L. Daniloff Y, et al. Increased urinary excretion of pyridinium crosslinks in cancer patients. Clin Chem 1993;39:614-8.